HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
TerminatedNCT00109577

Clinical Trial of a Nutritional Supplement in Adults With Bipolarity

Researchers are comparing MCN36 (nutritional supplement) and placebo to find out how the approaches affect manic symptoms in adults with bipolarity.

Medication studyAges 18+United States + Canada
The study in practice

Understand this study

What is this study about?

Researchers are comparing MCN36 (nutritional supplement) and placebo to find out how the approaches affect manic symptoms in adults with bipolarity.

Who could participate?

This study is for people with bipolarity. Listed age limits: from 18 years. Other eligibility criteria apply.

Listed locations
San Diego and 1 more locationSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateApril 2005
Recruitment status
Terminated
Enrollment listed in the registry
40
Sponsor
University of Calgary
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States, Canada
Age range
Over 18 Years
Official registry ID
NCT00109577
Official title
Show the full official title

Randomized Placebo-controlled Phase II Trial of MCN36 in Adults With Bipolar Disorder

Recruitment & locations

Terminated

San Diego, United States · Calgary, Canada

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What is this study about?

Researchers are comparing MCN36 (nutritional supplement) and placebo to find out how the approaches affect manic symptoms in adults with bipolarity.

Who is behind this study?

The study sponsor is University of Calgary, a university.

Does this study involve medication?

Yes. The study involves medication, including MCN36 (nutritional supplement) and Placebo.

Who can participate?

This study is for people with bipolarity. Listed age limits: from 18 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies